Can Human Vaccines aid Fishes? Know the Recent Developments in Vaccination in Fish

Disease is one of the most important limiting factors in aquaculture. Optimal husbandry and general management - including biosecurity, nutrition, genetics, system management and water quality - are critical for maximizing aquatic animal health

The vaccine is used to establish or improve the immunity against a specific disease or group of diseases. In aquaculture practices, there is always a chance of pathogenic outbreaks, which will affect the production of the farm. Aquaculture vaccines are used to protect the fishes from any pathogen.

Download Sample Brochure

The aquaculture vaccines market is anticipated to grow in the forecast period owing to growth in aquaculture farming practices, regulations and restrictions on the use of antibiotics in aquaculture, increasing research and development activities and growing prevalence of viral and bacterial infections in aquaculture species.

The "Global Aquaculture Vaccines Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of aquaculture vaccines market with detailed market segmentation by vaccine type, application, species type, route of administration and geography. The global aquaculture vaccines market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading aquaculture vaccines market players and offers key trends and opportunities in the market.

Top Companies Mentioned are -

• Benchmark Holdings plc
• HIPRA
• Intervet Inc. (Merck & Co. Inc.)
• Nisseiken Co., Ltd.
• Ridgeway Biologicals Ltd, Company (IDT Biologika)
• Tecnovax
• Vaccibody AS
• VETERQUIMICA SA
• Virbac
• Zoetis